Choroidal Neovascularization Market Size, Share, Growth, Trends, and Forecast by 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: Choroidal Neovascularization Market covers analysis By Route of Administration (Intravenous, Intravitreal), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00016865
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

MARKET INTRODUCTION



Neovascularization refers to the term new blood vessels. Choroidal neovascularization is abnormal condition where, new blood vessels originates from choroid, a layer situated under the retina. The occurrence of this condition is majorly observed in patients with AMD (Age-related Macular Degeneration). Vision distortion is one of the prominent symptom of CNV (Choroidal Neovascularization).

MARKET DYNAMICS



The choroidal neovascularization market is expected to witness considerable growth due to rise in geriatric population. Moreover, increasing research in drug development for the treatment of choroidal neovascularization is also expected to drive the market growth. However, lack of awareness amongst general populations, especially in emerging countries is estimated to hamper the growth of the global choroidal neovascularization market.

MARKET SCOPE



The "Choroidal Neovascularization Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Choroidal Neovascularization Market with detailed market segmentation by route of administration. The Choroidal Neovascularization Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Choroidal Neovascularization Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION



The Choroidal Neovascularization Market is segmented on the basis of route of administration. Based on route of administration, the market is segmented as intravenous and intravitreal.

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Choroidal Neovascularization Market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Choroidal Neovascularization Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Choroidal Neovascularization Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Choroidal Neovascularization Market in these regions.

MARKET PLAYERS



The report covers key developments in the Choroidal Neovascularization Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Choroidal Neovascularization Market are anticipated to have lucrative growth opportunities in the future with the rising demand for smart hospital beds in the global market. Below mentioned is the list of few companies engaged in the Choroidal Neovascularization Market.

The report also includes the profiles of key players in Choroidal Neovascularization Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Affitech A/S
  •  F. Hoffmann-La Roche Ltd.
  •  Lpath, Inc.
  •  Mat Biopharma
  •  Promedior, Inc.
  •  Regeneron Pharmaceuticals, Inc.
  •  Resolvyx Pharmaceuticals, Inc
  •  Sanwa Kagaku Kenkyusho Co., Ltd

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Choroidal Neovascularization Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) XX%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Route of Administration
  • Intravenous
  • Intravitreal
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Affitech A/S
  • F. Hoffmann-La Roche Ltd.
  • Lpath, Inc.
  • Mat Biopharma
  • Promedior, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Resolvyx Pharmaceuticals, Inc
  • Sanwa Kagaku Kenkyusho Co., Ltd.
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    choroidal-neovascularization-market-report-deliverables-img1
    choroidal-neovascularization-market-report-deliverables-img2
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    This text is related
    to segments covered.

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    This text is related
    to country scope.

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    Choroidal Neovascularization Market
    Connect With Expert
    The List of Companies

    1. Affitech A/S
    2. F. Hoffmann-La Roche Ltd.
    3. Lpath, Inc.
    4. Mat Biopharma
    5. Promedior, Inc.
    6. Regeneron Pharmaceuticals, Inc.
    7. Resolvyx Pharmaceuticals, Inc
    8. Sanwa Kagaku Kenkyusho Co., Ltd.
    choroidal-neovascularization-market-cagr